2 June 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Notice of AGM and posting of Annual Report
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that the Company's Annual Report and Accounts for the year ended 31 January 2023 and the notice of its Annual General Meeting ("AGM") 2023 have now been sent to shareholders and published on the Company's website at www.inspirationhealthcaregroup.com
Annual General Meeting and voting
The AGM of Inspiration Healthcare will be held at 11:30am (UK time) on Tuesday, 27 June 2023 at Unit 7/8 Commerce Park, Commerce Way, Croydon, CR0 4YL.
Voting by proxy
Shareholders will not receive a hard copy form of proxy for the AGM in the post. Instead, shareholders will be able to appoint a proxy electronically using the link www.signalshares.com. Shareholders will need to log into their Signal Shares account or register if that shareholder has not previously done so. To register shareholders will need their Investor Code, this is detailed on the share certificate or available from our Registrars, Link Group. Proxy votes must be received by no later than 11.30 am on 23 June 2023. Alternatively, shareholders may submit their proxy vote via CREST where applicable.
Request a hard copy form of proxy
Shareholders may request a hard copy form of proxy directly from the Registrars, Link Group on 0371 664 0300. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. Lines are open between 09:00 - 17:30, Monday to Friday excluding public holidays in England and Wales. Alternatively, shareholders can request a hard copy proxy card by emailing shareholderenquiries@linkgroup.co.uk.
Enquiries:
| Inspiration Healthcare Group plc | Tel: +44 (0)330 175 0000
|
| Neil Campbell, Chief Executive Officer | |
| Paul Bergin, Interim Chief Financial Officer | |
|
| |
|
| |
| Liberum (Nominated Adviser & Broker) | Tel: +44 (0)20 3100 2000 |
| Phil Walker, Richard Lindley, William Hall, Will King | |
|
| |
|
| |
| Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
| Anna Dunphy | Mob: +44 (0) 7876 741 001 |
| Stephanie Cuthbert | Mob: +44 (0) 7796 794 663 |
| Louis Ashe-Jepson | Mob: +44 (0) 7747 515 393 |
About Inspiration Healthcare Group
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.
The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.
In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS
The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.
www.inspirationhealthcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.